Exact Mass: 607.2212918
Exact Mass Matches: 607.2212918
Found 54 metabolites which its exact mass value is equals to given mass value 607.2212918
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Cys His Trp Tyr
Cys His Tyr Trp
Cys Asn Trp Trp
Cys Trp His Tyr
Cys Trp Asn Trp
Cys Trp Trp Asn
Cys Trp Tyr His
Cys Tyr His Trp
Cys Tyr Trp His
His Cys Trp Tyr
His Cys Tyr Trp
His Trp Cys Tyr
His Trp Tyr Cys
His Tyr Cys Trp
His Tyr Trp Cys
Asn Cys Trp Trp
Asn Trp Cys Trp
Asn Trp Trp Cys
Trp Cys His Tyr
Trp Cys Asn Trp
Trp Cys Trp Asn
Trp Cys Tyr His
Trp His Cys Tyr
Trp His Tyr Cys
Trp Asn Cys Trp
Trp Asn Trp Cys
Trp Trp Cys Asn
Trp Trp Asn Cys
Trp Tyr Cys His
Trp Tyr His Cys
Tyr Cys His Trp
Tyr Cys Trp His
Tyr His Cys Trp
Tyr His Trp Cys
Tyr Trp Cys His
Tyr Trp His Cys
Torin 1
Torin 1 is a potent inhibitor of mTOR with an IC50 of 3 nM. Torin 1 inhibits both mTORC1/2 complexes with IC50 values between 2 and 10 nM. Torin 1 is an effective inducer of autophagy. Torin 1 is a potent inhibitor of mTOR with an IC50 of 3 nM. Torin 1 inhibits both mTORC1/2 complexes with IC50 values between 2 and 10 nM. Torin 1 is an effective inducer of autophagy.
N-[(2R,4aS,12aR)-2-[2-(2,3-dihydro-1H-inden-2-ylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-(trifluoromethyl)benzamide
C33H32F3N3O5 (607.2293937999999)
N-coumaroyl tyramine-4,4-O-beta-D-diglucoside
C29H37NO13 (607.2264792000001)
N-[(2S,4aR,12aR)-2-[2-(2,3-dihydro-1H-inden-2-ylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-(trifluoromethyl)benzamide
C33H32F3N3O5 (607.2293937999999)
N-[(2R,4aR,12aS)-2-[2-(2,3-dihydro-1H-inden-2-ylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-(trifluoromethyl)benzamide
C33H32F3N3O5 (607.2293937999999)
N-[(2S,4aS,12aS)-2-[2-(2,3-dihydro-1H-inden-2-ylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-(trifluoromethyl)benzamide
C33H32F3N3O5 (607.2293937999999)
N-[(2R,4aR,12aR)-2-[2-(2,3-dihydro-1H-inden-2-ylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-(trifluoromethyl)benzamide
C33H32F3N3O5 (607.2293937999999)
N-[(2S,4aR,12aS)-2-[2-(2,3-dihydro-1H-inden-2-ylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-(trifluoromethyl)benzamide
C33H32F3N3O5 (607.2293937999999)
N-[(4R,7R,8S)-5-(4-chlorophenyl)sulfonyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
(1s,2s,3s,4s,5r,6r,7s,9r,12r)-4,5,12-tris(acetyloxy)-6-[(acetyloxy)methyl]-2,3-dihydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl pyridine-3-carboxylate
C29H37NO13 (607.2264792000001)
(2s,9s,9as)-9-hydroxy-9-{[(1r,4s)-3-hydroxy-1-methyl-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl]methyl}-2-methyl-1-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-2h,9ah-imidazo[1,2-a]indol-3-one
9-hydroxy-9-({3-hydroxy-1-methyl-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl}methyl)-2-methyl-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-2h,9ah-imidazo[1,2-a]indol-3-one
(2s,9s,9as)-9-hydroxy-9-{[(1s,4s)-3-hydroxy-1-methyl-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl]methyl}-2-methyl-1-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-2h,9ah-imidazo[1,2-a]indol-3-one
(1r,2r,3s,4s,5s,6s,7s,9s,12r)-4,5,12-tris(acetyloxy)-6-[(acetyloxy)methyl]-2,3-dihydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl pyridine-3-carboxylate
C29H37NO13 (607.2264792000001)
4,5,12-tris(acetyloxy)-6-[(acetyloxy)methyl]-2,3-dihydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl pyridine-3-carboxylate
C29H37NO13 (607.2264792000001)